Arcus Biosciences, Inc. ( RCUS) - Key Metrics
RCUS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.33 | -$0.72 | -$0.94 | -$0.94 |
| 2026Q1 | $0.14 | -$1.02 | -$1.10 | -$1.10 |
| 2025Q4 | $0.31 | -$0.91 | -$1.12 | -$1.13 |
| 2025Q3 | $0.24 | -$1.27 | -$0.91 | -$0.91 |
| 2025Q2 | $1.51 | -$0.08 | -$1.25 | -$1.25 |
RCUS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.70 |
| 2026Q1 | 0% | -5.29 |
| 2025Q4 | 0% | -6.48 |
| 2025Q3 | 0% | -2.68 |
| 2025Q2 | 0% | -25.44 |
RCUS
Price: $29.48
52 week price:
Earnings Per Share: -3.94 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 965900
Market Capitalization: 3.6 billion